Health economics of osteoporosis

被引：24

作者：

Borgstrom, Fredrik ^{[1
,2
]}

Kanis, John A. ^{[3
]}

机构：

[1] Karolinska Inst, Med Management Ctr, Stockholm 17177, Sweden

[2] i3 Innovus, SE-11120 Stockholm, Sweden

[3] Univ Sheffield, Sch Med, WHO Collaborating Ctr Metab Bone Dis, Sheffield S10 2RX, S Yorkshire, England

来源：

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2008年 / 22卷 / 05期

关键词：

osteoporosis; fractures; health economics; cost-effectiveness;

D O I：

10.1016/j.beem.2008.07.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Rather than reviewing the many studies of cost effectiveness in osteoporosis, this paper reviews the principles of cost-effectiveness analysis and the gaps in our knowledge that are required to improve such analyses in osteoporosis. These include more information on the cost of fractures and their consequences on health states, particularly on an international basis. New developments include the incorporation of adherence into models, the use of the FRAX (TM) tool to assess cost-effectiveness in individuals with any combination of risk factors for fracture, and the setting of intervention thresholds based on cost-effectiveness.

引用

页码：885 / 900

页数：16

共 55 条

[31] The burden of osteoporotic fractures: A method for setting intervention thresholds [J].

Kanis, JA ;

Oden, A ;

Johnell, O ;

Jonsson, B ;

de Laet, C ;

Dawson, A .

OSTEOPOROSIS INTERNATIONAL, 2001, 12 (05) :417-427

[32] The cost-effectiveness of alendronate in the management of osteoporosis [J].

Kanis, John A. ;

Adams, Judith ;

Borgstrom, Fred ;

Cooper, Cyrus ;

Jonsson, Bengt ;

Preedy, Danielle ;

Selby, Peter ;

Compston, Juliet .

BONE, 2008, 42 (01) :4-15

[33] Diagnosis and treatment of postmenopausal osteoporosis and osteoporosis in men: German guidelines update 2006 [J].

Kurth A.A. ;

Pfeilschifter J. .

Der Orthopäde, 2007, 36 (7) :683-692

[34] Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures [J].

Marshall, D ;

Johnell, O ;

Wedel, H .

BRITISH MEDICAL JOURNAL, 1996, 312 (7041) :1254-1259

[35] Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures [J].

Oleksik, A ;

Lips, P ;

Dawson, A ;

Minshall, ME ;

Shen, W ;

Cooper, C ;

Kanis, J .

JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (07) :1384-1392

[36] Direct costs of hip fractures in patients over 60 years of age in Belgium [J].

Reginster, JY ;

Gillet, P ;

Ben Sedrine, W ;

Brands, G ;

Ethgen, O ;

de Froidmont, C ;

Gosset, C .

PHARMACOECONOMICS, 1999, 15 (05) :507-514

[37] Quality of life related to fear of falling and hip fracture in older women: a time trade off study [J].

Salkeld, G ;

Cameron, ID ;

Cumming, RG ;

Easter, S ;

Seymour, J ;

Kurrle, SE ;

Quine, S .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7231) :341-345

[38] Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-Score >-2.5 for alendronate therapy:: A modeling study [J].

Schousboe, John T. ;

Ensrud, Kristine E. ;

Nyman, John A. ;

Kane, Robert L. ;

Melton, L. Joseph, III .

JOURNAL OF CLINICAL DENSITOMETRY, 2006, 9 (02) :133-143

[39] Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland [J].

Schwenkglenks, M. ;

Lippuner, K. .

OSTEOPOROSIS INTERNATIONAL, 2007, 18 (11) :1481-1491

[40] Non-compliance:: the Achilles' heel of anti-fracture efficacy [J].

Seeman, E. ;

Compston, J. ;

Adachi, J. ;

Brandi, M. L. ;

Cooper, C. ;

Dawson-Hughes, B. ;

Jonsson, B. ;

Pols, H. ;

Cramer, J. A. .

OSTEOPOROSIS INTERNATIONAL, 2007, 18 (06) :711-719

← 1 2 3 4 5 6 →